Research Journal of Biotechnology

Indexed in Web of Science, SCOPUS, BioTechnology Citation Index®, Chemical Abstracts,
Biological Abstracts, ESCI, UGC, NAAS, Indian Citation Index etc.



Please donate Rs.7000 per plant to WRA for our plantation drive to help create a better environment.



WRA Plantation - 50,000 trees grown on rocks and stones on barren rocky hillock "Keshar Parvat".






Phytochemical and Anatomical Profiling of Terminalia catappa Linn., Fruit Rinds: A Multi-Targeted Approach to Resistant Human Pathogens

Thomas Sowmya and George Jeya Jothi

Res. J. Biotech.; Vol. 21(1); 38-51; doi: https://doi.org/10.25303/211rjbt038051; (2026)

Abstract
Terminalia catappa Linn. is a pharmaceutically recognized avenue tree belonging to the family Combretaceae. Various parts of the plant are recognized for their anti-diabetic, antioxidant and antibacterial potential. This study aimed to comprehensively analyse the anatomy, histochemical compounds, phytochemical compounds, secondary metabolites through the Gas Chromatography Mass Spectrometry (GC-MS) characterization and antibacterial properties. Different solvents, ranging from low-polarity to high-polarity solvents, were employed to extract various phytocompounds. Qualitative and quantitative phytochemical screening confirmed the presence of alkaloids, flavonoids, terpenoids, tannins and other secondary metabolites, with the aqueous extract showing the highest concentrations of phenols, flavonoids and tannins.

The antibacterial screening demonstrated efficient activity of ethanolic and aqueous extracts against a wide spectrum of Gram-positive and Gram-negative bacteria by following the agar-well method, with the ethanolic extract showing the highest zones of inhibition. The GC–MS analysis identified significant secondary metabolites, having potent antibacterial properties. This research underscores the pharmaceutical applications of T catappa fruit rinds (TCFR) and contributes to the developing interest in organic research by providing insights into the bioactive compounds of TCFR and the development of plant-based multi-drug-resistant (MDR) antibacterial therapeutics.